KM11060 100 mg | 99.67%
TargetMol

KM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.
More Information Supplier PageKM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.
More Information Supplier PageKM11060 is a novel corrector of the F508del-CFTR trafficking defect, Correcting F508del-CFTR trafficking, increasing the amount of functional CFTR at the plasma membrane.
More Information Supplier PageF 11440 is a highly effective and selective 5-HT1A receptor agonist with marked antidepressant and anxiolytic potential.
More Information Supplier PageF 11440 is a highly effective and selective 5-HT1A receptor agonist with marked antidepressant and anxiolytic potential.
More Information Supplier PageBIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageBIBS 39 is a new nonpeptide angiotensin II (AII) receptor antagonist.
More Information Supplier PageNotoginsenoside R1 has been shown to exhibit antioxidant, antiapoptotic, anti-inflammatory, and immune-stimulatory properties.
More Information Supplier PageHonokiol is the active principle of magnolia extract. It inhibits the activation of Akt and enhances the phosphorylation of ERK1/ERK2.
More Information Supplier Page